Skip to content
New website under construction. Stay tuned!
Insight: Industry Presentations
Calendar of Events
Boehringer, Dicerna pen $201M pact to hit NASH with RNAi
New frontiers in COPD — what’s next on the treatment horizon?
Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3’s significant potential role in Immuno-Oncology at SITC Annual Meeting